Literature DB >> 1692665

Studies of the outer membrane proteins of Branhamella catarrhalis.

T F Murphy1.   

Abstract

PURPOSE: Branhamella catarrhalis has emerged as an important human pathogen in the past several years. Therefore, studies of the outer membrane have been undertaken in order to identify virulence factors and begin to understand the immune response to infection.
MATERIALS AND METHODS: The outer membrane of B. catarrhalis has been purified by sucrose density centrifugation. The outer membrane proteins (OMPs) of 50 strains from diverse sources were isolated by simpler methods and studied by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Experiments were designed to identify OMPs that express determinants on the surface of the intact bacterium.
RESULTS: Eight major OMPs have been identified (OMPs A through H). The OMP patterns from diverse strains were strikingly similar. OMP E (approximately 56,000 daltons) and OMP G (approximately 28,000 daltons) have determinants that are surface-exposed and these determinants are shared among a majority of strains of B. catarrhalis.
CONCLUSION: These observations have important implications with regard to the immune response to infection and future vaccine development.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692665     DOI: 10.1016/0002-9343(90)90261-b

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

1.  Identification and characterization of a novel outer membrane protein (OMP J) of Moraxella catarrhalis that exists in two major forms.

Authors:  John P Hays; Saskia van Selm; Theo Hoogenboezem; Silvia Estevão; Kimberly Eadie; Peter van Veelen; Jan Tommassen; Alex van Belkum; Peter W M Hermans
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

2.  Antigenic characterization and analysis of the human immune response to outer membrane protein E of Branhamella catarrhalis.

Authors:  R Bhushan; C Kirkham; S Sethi; T F Murphy
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  Human antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalis.

Authors:  Diana G Adlowitz; Sanjay Sethi; Paul Cullen; Ben Adler; Timothy F Murphy
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 4.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

5.  Molecular cloning and characterization of outer membrane protein E of Moraxella (Branhamella) catarrhalis.

Authors:  R Bhushan; R Craigie; T F Murphy
Journal:  J Bacteriol       Date:  1994-11       Impact factor: 3.490

6.  Lack of serotype-specific antibody response to lipopolysaccharide antigens of Moraxella catarrhalis during lower respiratory tract infection.

Authors:  M Rahman; T Holme; I Jönsson; A Krook
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

7.  Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis.

Authors:  J Sarwar; A A Campagnari; C Kirkham; T F Murphy
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

8.  Variability of surface-exposed antigens of different strains of Moraxella catarrhalis.

Authors:  I Jönsson; T Holme; A Krook; M Rahman; M Thorén
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-10       Impact factor: 3.267

9.  Purification and characterization of a high-molecular-weight outer membrane protein of Moraxella (Branhamella) catarrhalis.

Authors:  K L Klingman; T F Murphy
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

10.  Identification of a bacteriocin and its cognate immunity factor expressed by Moraxella catarrhalis.

Authors:  Ahmed S Attia; Jennifer L Sedillo; Todd C Hoopman; Wei Liu; Lixia Liu; Chad A Brautigam; Eric J Hansen
Journal:  BMC Microbiol       Date:  2009-09-25       Impact factor: 3.605

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.